波谱学杂志

• •    

雌激素、肿瘤标志物联合DCE-MRI在宫颈癌诊断及临床分期中的应用

左冰玉,石丽莉*,宋佳,赵阳,李倩   

  1. 唐山市妇幼保健院放射科,河北 唐山 063000
  • 收稿日期:2024-10-16 修回日期:2025-01-16 出版日期:2025-01-16 在线发表日期:2025-01-16
  • 通讯作者: 石丽莉 E-mail:zhimei956491@163.com

Application of estrogen and tumor markers combined with DCE-MRI in diagnosis and clinical staging of cervical cancer

ZUO Bingyu,SHI Lili*,SONG Jia,ZHAO Yang,LI Qian   

  1. Radiology Department of Tangshan Maternal and Child Health Hospital, Tangshan 063000, China
  • Received:2024-10-16 Revised:2025-01-16 Published:2025-01-16 Online:2025-01-16
  • Contact: SHI Lili E-mail:zhimei956491@163.com

摘要: 准确可靠的宫颈癌诊断是临床治疗和预后评估的关键,针对现有的血清雌激素、肿瘤标志物单独评估其宫旁浸润、淋巴结转移等病变特征敏感性较低,本文提出一种联合磁共振多期动态增强成像(DCE-MRI)的诊断方法,首先对患者进行血清雌二醇(E2)、促卵泡生成素(FSH)、促黄体生成素(LH)、糖链抗原125(CA125)、糖链抗原19-9(CA19-9)及DCE-MRI检测,分析宫颈癌分期与血清E2、FSH、LH、CA125、CA19-9水平相关性;然后,以宫颈活检结果为金标准,分析DCE-MRI对宫颈癌深肌层浸润、淋巴结转移的诊断准确率;最后,以受试者工作特征曲线(ROC)分析血清E2、FSH、LH、CA125、CA19-9水平、DCE-MRI诊断及联合诊断方法对宫颈癌的诊断价值.实验结果表明,联合诊断的曲线下面积(AUC)为0.908,这表明联合诊断方法可较好区分宫颈病变的良恶性,而基于DCE-MRI参数KtransKep也进一步丰富了特征信息,从而提高病灶的检出精度,为宫颈癌良恶性鉴别及其临床分期诊断提供了新方法.

关键词: 雌激素, 肿瘤标志物, 磁共振多期动态增强成像, 宫颈癌, 联合诊断

Abstract:

Accurate and reliable diagnosis of cervical cancer is the key to clinical treatment and prognosis evaluation. In view of the low sensitivity of the existing serum estrogen and tumor markers to evaluate the features of the lesions, such as parauterine invasion and lymph node metastasis, a diagnostic method combined with multi-phase dynamic enhanced magnetic resonance imaging (DCE-MRI) was proposed in this paper. Firstly, serum estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), glycochain antigen 125 (CA125), glycochain antigen 19-9 (CA19-9) and DCE-MRI were detected to analyze the correlation between cervical cancer stage and serum levels of E2, FSH, LH, CA125 and CA19-9. Then, cervical biopsy results were used as the gold standard to analyze the diagnostic accuracy of DCE-MRI for cervical deep muscle invasion and lymph node metastasis. Finally, the serum levels of E2, FSH, LH, CA125, CA19-9, DCE-MRI diagnosis and combined diagnosis of cervical cancer were analyzed based on receiver operating characteristic (ROC) curve. The experimental results showed that the AUC of combined diagnosis was 0.908, indicating that the combined diagnosis method could better distinguish benign and malignant cervical lesions, and the DCE-MRI parameters Ktrans and Kep further enriched the feature information, thereby improving the detection accuracy of lesions, and providing a new method for the differentiation of benign and malignant cervical cancer and its clinical staging.

Key words: estrogen, tumor markers, dynamic enhanced nuclear magnetic resonance, cervical cancer, joint diagnosis